JH
Jaguar Health, Inc.
SEC filingPharmaceuticals · San Francisco, CA
Amount raised$2Msold at filing
Total offering$2M
Investors in the raise2count reported to the SEC
FiledJul 1, 2026first sale Jun 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
John Micek IIIDirector
Carol LizakExecutive Officer
Lisa ConteExecutive Officer, Director
Steven KingExecutive Officer
Pravin ChaturvediExecutive Officer
Jonathan WolinExecutive Officer
Anula JayasuriyaDirector
Jonathan SiegelDirector
James BochnowskiDirector
Executive officers, directors and promoters as listed on the Form D.